MDMA/Synthesis: Difference between revisions
>Kenan m Use proper synth for MDMA by shulgin (previous was MDPEA by mistake) |
>Kenan m Seems like the OCR doesn't like shulgins' D |
||
Line 38: | Line 38: | ||
=== Synthesis === | === Synthesis === | ||
* From safrole (with aqueous HBr) to 5-(2-bromopropyl)benzo-1,3-dioxole; (with methyl amine in EtOH) to | * From safrole (with aqueous HBr) to 5-(2-bromopropyl)benzo-1,3-dioxole; (with methyl amine in EtOH) to MDMA (Merck, 1912; Bineicki and Krajewski, 1960). | ||
* From 3,4-methylenedioxyphenylacetone (aka: piperonylacetone; with methylamine, sodium cyanoborohydride) to | * From 3,4-methylenedioxyphenylacetone (aka: piperonylacetone; with methylamine, sodium cyanoborohydride) to MDMA (Braun et al., 1980). | ||
* From | * From MDA (with formic acid or ethyl formate) to ''N''-formyl-3,4-methylenedioxy amphetamine; (with LAH) to MDMA (Shulgin and Shulgin, 1991) | ||
* From isosafrole (with formic acid, H<sub>2</sub>0<sub>2</sub>) to 3,4-methylenedioxyphenylacetone; (with Al, HgCl<sub>2</sub>, CH<sub>3</sub>NH<sub>2</sub>) to | * From isosafrole (with formic acid, H<sub>2</sub>0<sub>2</sub>) to 3,4-methylenedioxyphenylacetone; (with Al, HgCl<sub>2</sub>, CH<sub>3</sub>NH<sub>2</sub>) to MDMA (Shulgin and Shulgin, 1991). | ||
* (For the optical isomers) from piperonylacetone (with ''R''-(-)- (or ''S''-(+)-) α-methylbenzyl amine, Raney Ni) to ''R'',''R''- (or ''S'',''S'') ''N''-α-methylbenzyl-MOA; (with Pd, H<sub>2</sub>) to ''R''-(-)- (or ''S''-(+)-) | * (For the optical isomers) from piperonylacetone (with ''R''-(-)- (or ''S''-(+)-) α-methylbenzyl amine, Raney Ni) to ''R'',''R''- (or ''S'',''S'') ''N''-α-methylbenzyl-MOA; (with Pd, H<sub>2</sub>) to ''R''-(-)- (or ''S''-(+)-) MDA; (with methyl formate) to ''R''-(+)- (or ''S''-(-) ''N''-formamido-MDA; (with LAH) to ''R''-(-) (or ''S''-(+)-) MDMA (Anderson et al., 1978a). | ||
== M. Swist, J. Wilamowski, A. Parczewski == | == M. Swist, J. Wilamowski, A. Parczewski == |